Tag: Manufacturing issues

Several batches of common eye drops and eye ointments were recalled throughout 2025 due to safety concerns identified by the U.S. Food and Drug Administration (FDA). These recalls highlight the ongoing importance for consumers to stay informed about product safety and know exactly what eye drops were recalled in 2025 to protect their vision.

According to the American Society of Health-System Pharmacists (ASHP), the number of active drug shortages in the U.S. remains critically high, with the shortage of essential medications like morphine being a persistent issue. Understanding why there is a shortage of morphine requires examining a complex interplay of manufacturing challenges, market economics, and stringent regulatory controls.